Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

NovaBay Pharmaceuticals Inc (NBY)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow NovaBay Pharmaceuticals's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
NovaBay Pharmaceuticals historical data, for real-time data please try another search
0.1656 +0.0066    +4.15%
16/02 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
ISIN:  US66987P3001 
CUSIP:  66987P300
  • Volume: 139,723
  • Bid/Ask: 1.0200 / 1.2000
  • Day's Range: 0.1515 - 0.1700
NovaBay Pharmaceuticals 0.1656 +0.0066 +4.15%

NovaBay Pharmaceuticals Inc Company Profile

 
Get an in-depth profile of NovaBay Pharmaceuticals Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

25

Equity Type

ORD

NovaBay Pharmaceuticals, Inc. develops and sells eyecare and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; Avenova Eye Health Support antioxidant-rich oral supplements; Avenova Lubricating Eye Drops for instant relief; NovaWipes by Avenova; Avenova WarmEye Compress to soothe the eyes; and the i-Chek by Avenova to monitor physical eyelid health. The company also provides wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. It sells its products through the company’s web stores, third-party online retailers and distribution partners. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Contact Information

Address 2000 Powell Street Suite 1150, eleventh floor
Emeryville, 94608
United States
Phone 510 899 8800
Fax 510 474 1577

Top Executives

Name Age Since Title
Paul E. Freiman 88 2002 Independent Chairman
Justin M. Hall 45 2015 President, CEO, General Counsel, Chief Compliance Officer, Corporate Secretary & Director
Laura M. Periman - 2020 Member of the Ophthalmic Advisory Board
Julie Garlikov 52 2022 Independent Director
Ahmad Fahmy - 2015 Member of Optometry Advisory Board
Mijia Wu 49 2016 Director
John Aljian - 2020 Member of the Ophthalmic Advisory Board
Melanie Bennett-Sims - 2020 Member of the Ophthalmic Advisory Board
Yongxiang Zheng 53 2022 Director
Milap Mehta - 2020 Member of the Ophthalmic Advisory Board
Pedram Hamrah - 2015 Member of Ophthalmic Advisory Board
William B. Trattler - 2020 Member of the Ophthalmic Advisory Board
Laura F. Kay - 2020 Member of the Optometry Advisory Board
Wendy Lee - 2020 Member of the Ophthalmic Advisory Board
Yenyou Zheng 67 2019 Independent Director
Guru Dutt Sharma - 2020 Member of the Optometry Advisory Board
Michaela Crowley - 2020 Member of the Optometry Advisory Board
Komal Thakore - 2020 Member of the Optometry Advisory Board
Michael Orozco - 2020 Member of the Optometry Advisory Board
Swan Sit 44 2019 Independent Director
Renee Bovelle - 2020 Member of the Ophthalmic Advisory Board
Brian Samartino - 2020 Member of the Optometry Advisory Board
Amr Kouchouk - 2020 Member of the Ophthalmic Advisory Board
Mark Cheung - 2020 Member of the Optometry Advisory Board
Jerry Robben - 2020 Member of the Optometry Advisory Board
Suzanne Walter Sherman - 2020 Member of the Optometry Advisory Board
Michelle Rhee - 2020 Member of the Ophthalmic Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NBY Comments

Write your thoughts about NovaBay Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Antony Agathangelos
Antony Agathangelos Nov 10, 2023 1:51PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this is about to fly soon....
Nhat Doan
Nhat Doan Dec 30, 2022 10:28AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
TEST CAN NOT SHORT MUST NOT BUY 🔊📢👹
omar ahmad
omar ahmad Sep 09, 2022 12:36PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Panagiotis Gk
Panagiotis Gk Jul 14, 2021 5:45AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
time to buy
Beer Time
Beer Time May 06, 2021 3:43AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
162028697528896.jpg
Earnings report today.
Beer Time
Beer Time Mar 25, 2021 12:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Bought at 0,95
Zoran Labus
Zoran Labus Mar 25, 2021 11:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://seekingalpha.com/pr/18243773-sellas-life-sciences-reports-full-year-2020-financial-results-and-provides-business-update
Arl Nn
ArlN Mar 19, 2021 1:51PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
They seem to have good earnings coming
Mikael Lauritsen
Mikael Lauritsen Mar 19, 2021 1:51PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
itll be amazing
Eddie Hakopyan
Eddie Hakopyan Mar 19, 2021 1:51PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
today there earnings how you think it's going to be
Arl Nn
ArlN Mar 19, 2021 1:51PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I wish I knew... These days, nothing seems to have any logic nor sense... Just a war between some groups of people...
The Quiter
The Quiter Feb 26, 2021 1:35PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Garbage
Beer Time
Beer Time Feb 09, 2021 6:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Target 1.90
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email